A prospective study to assess the impact and benefits of an artificial intelligence system in double reading for breast cancer screening
Not Applicable
Active, not recruiting
- Conditions
- Breast cancerCancer
- Registration Number
- ISRCTN95571932
- Lead Sponsor
- Kheiron Medical Technologies (United Kingdom)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Female
- Target Recruitment
- 6876
Inclusion Criteria
1. Participants routinely invited or self-referred for breast screening
2. Participants identified as female
3. Participants for whom a 2D FFDM standard four-view mammography examination was acquired
Exclusion Criteria
1. Patients with cosmetic breast implants
2. Very high risk patients, including genetic abnormalities etc.
3. Patients who have actively dissented from participation in the study
4. Cases marked as technical recall
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method